Your browser doesn't support javascript.
loading
High-Fat Diet-Induced Diabetic Conditions Exacerbate Cognitive Impairment in a Mouse Model of Alzheimer's Disease Via a Specific Tau Phosphorylation Pattern.
Ito, Y; Takeda, S; Nakajima, T; Oyama, A; Takeshita, H; Miki, K; Takami, Y; Takeya, Y; Shimamura, M; Rakugi, H; Morishita, R.
Affiliation
  • Ito Y; Shuko Takeda, MD, PhD and Ryuichi Morishita, MD, PhD, Department of Clinical Gene Therapy, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan, Tel: 81-6-6210-8351, Fax: 81-6-6210-8354, Email: takeda@cgt.med.osaka-u.ac.jp and morishit@cgt.med.osaka-u.ac.jp.
J Prev Alzheimers Dis ; 11(1): 138-148, 2024.
Article in En | MEDLINE | ID: mdl-38230726
ABSTRACT

BACKGROUND:

Epidemiological evidence has demonstrated a clear association between diabetes mellitus and increased risk of Alzheimer's disease (AD). Cerebral accumulation of phosphorylated tau aggregates, a cardinal neuropathological feature of AD, is associated with neurodegeneration and cognitive decline. Clinical and experimental studies indicate that diabetes mellitus affects the development of tau pathology; however, the underlying molecular mechanisms remain unknown.

OBJECTIVE:

In the present study, we used a unique diabetic AD mouse model to investigate the changes in tau phosphorylation patterns occurring in the diabetic brain.

DESIGN:

Tau-transgenic mice were fed a high-fat diet (n = 24) to model diabetes mellitus. These mice developed prominent obesity, severe insulin resistance, and mild hyperglycemia, which led to early-onset neurodegeneration and behavioral impairment associated with the accumulation of hyperphosphorylated tau aggregates.

RESULTS:

Comprehensive phosphoproteomic analysis revealed a unique tau phosphorylation signature in the brains of mice with diabetic AD. Bioinformatic analysis of the phosphoproteomics data revealed putative tau-related kinases and cell signaling pathways involved in the interaction between diabetes mellitus and AD.

CONCLUSION:

These findings offer potential novel targets that can be used to develop tau-based therapies and biomarkers for use in AD.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Alzheimer Disease / Cognitive Dysfunction Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: J Prev Alzheimers Dis Year: 2024 Document type: Article Country of publication: Suiza

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Alzheimer Disease / Cognitive Dysfunction Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: J Prev Alzheimers Dis Year: 2024 Document type: Article Country of publication: Suiza